EOM Pharmaceutical Holdings Inc. (IMUC)

[OTC_Hussler]

Haha. Nope. But there was a 30 day quiet period after canceling the funding raise.

Trial seems positive.

Not sure where they go from here but they have to have some funding plan to further trials.

They should be wrapping up testing on toxicity of their EOM613.

“Results indicate that EOM613 treatment mitigates cytokine release in patients with COVID-19 pulmonary vascular inflammation.”